I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Contraception

Helping your patients make the right choice

With rising abortion rates, particularly among women aged 30–34, there is a clear need to offer the most effective contraceptive methods.1 In a quantitative survey of over 430 women and their experiences of unintended pregnancy and abortion, over half were using contraception at the time they became pregnant.2 Long-acting methods can be the most effective form of contraception because they do not rely on user compliance.3

Here you will find resources to guide conversations with your patients, helping to identify which is the most suitable contraception for them.

  1. Department of Health. Abortion statistics, England and Wales: 2016/2017. Available at: https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2017. Last accessed: October 2019.
  2. Bury, Louise; Hoggart, Lesley and Newton, Victoria Louise (2015). Young women’s experiences of unintended pregnancy and abortion: key findings. The Open University, Milton Keynes, UK. Available at: https://oro.open.ac.uk/45138/1/MSI_key-findings_10-15_email.pdf. Last accessed: October 2019.
  3. Cristobal I, et al. Eur J Obstet Gynecol Reprod Biol 2015;190:58–64.

Use the Range of contraception leaflet with your patients to discuss the different options available and to help them make an informed decision on which contraception is best for them.

Download

Use the Range of contraception leaflet with your patients to discuss the different options available and to help them make an informed decision on which contraception is best for them.

Download

Pill compliance is a common struggle for women1

Pill compliance

For every 100 women that choose to take the pill this year, nine could become pregnant due to missed-pill moments.2 Long-acting methods such as intrauterine systems (IUS) offer birth control with the highest available efficacy and are one of the most effective contraceptive methods because their effectiveness is independent of user compliance.3

  1. Merki-Feld GS, et al. Eur J Contracep Reprod Health Care 2018:183–193.
  2. NHS. How effective is contraception at preventing pregnancy? - Your contraception guide [online]. Updated 30 June 2017. Available from: https://www.nhs.uk/conditions/contraception/how-effective-contraception/ [Last accessed: November 2019].
  3. Cristobal I, et al. Eur J Obstet Gynecol Reprod Biol 2015;190:58–64.

Choose an IUS that best meets her needs

  Jaydess®1
13.5 mg intrauterine delivery system (levonorgestrel)
Kyleena®2
19.5 mg intrauterine delivery system (levonorgestrel)
Mirena®3
52 mg intrauterine delivery system (levonorgestrel)
Indication Contraception for up to 3 years Contraception for up to 5 years Contraception for up to 5 years Treatement of HMB for up to 5 years endometrial protection during HRT for 4 years
Pearl Index (efficacy) Year 1:0.41
3-years: 0:33
Year 1: 0.16
5-years: 0.29
Year 1: 0.2
Years 5: 0.144
Contraceptive failure rate 0.4% at 1 year
0.9% over 3 years
0.2% at 1 year
1.4% over 5 years
0.2% at 1 year
0.7% over 5 years
Total levonorgestrel (LNG) content (mg) 13.5 19.5 52
Average in vivo LNG release rate over the first year of use 8 μg/24 hours 12.6 μg/24 hours2 20 μg/24 hours
% of women experiencing amenorrhoea and infrequent bleeding at 1 year post insertion Amenorrhoea: 6%
infrequent bleeding: 20%
Amenorrhoea: 12%
infrequent bleeding: 26%
Amenorrhoea: 16%
infrequent bleeding: 57%
T-frame size (mm) 28 × 30 28 × 30 32 × 324
Placement tube diameter size (mm) 3.8 3.8 4.4
Colour of monofilament threads Brown Blue Brown
Differentiator in imaging techniques:silver ring Improved visibility on ultrasound Improved visibility on ultrasound -

  1. Bayer Plc. Jaydess®▼13.5 mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated 12 June 2019. Available from: https://www.medicines.org.uk/emc/product/5297/smpc [Last accessed: September 2019].
  2. Bayer Plc. Kyleena® 19.5 mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated 02 May 2019. Available from: https://www.medicines.org.uk/emc/product/769/smpc [Last accessed: September 2019].
  3. Bayer Plc. Mirena® 52 mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated 17 October 2019. Available from: https://www.medicines.org.uk/emc/product/1132/smpc [Last accessed: August 2019].
  4. Bayer Plc. Mirena® 52 mg intrauterine delivery system (levonorgestrel): Product Information. Bayer Australia. Updated 11 October 2018.

Patient misconceptions are a common reason why IUS are not more widely used, despite being one of the most effective contraceptive methods available.1

Counsel your patients’ concerns around IUS with these common myth busters

Download

  1. Cristobal I, et al. Eur J Obstet Gynecol Reprod Biol 2015;190:58–64.
HMB

If you are a fitter of IUS, visit Fitter resources which covers all the practical aspects of the IUS/IUD fitting process, including preparation and loading advice. 

Fitter resources

Recommendations

Bayer in women's health

Read more

Menorrhagia

Read more

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0255 November 2019

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Tue, 08/11/2020 - 10:24

Bayer logo